Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled Through ERK-Dependent Mechanisms
Journal of Immunology - United States
doi 10.4049/jimmunol.174.12.7859
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2005
Authors
Publisher
The American Association of Immunologists